Keywords: عروق خونی هدف; ACS; acute coronary syndrome; CABG; coronary artery bypass grafting; CAD; coronary artery disease; IABP; intra-aortic balloon pump; LM; left main; MACE; major adverse cardiac event; MI; myocardial infarction; NSTEMI; non-ST-elevation myocardial infarction
مقالات ISI عروق خونی هدف (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: عروق خونی هدف; CAD; coronary artery disease; DAPT; dual anti-platelet therapy; DES; drug eluting stent; DM; diabetes mellitus; L-DAPT; long dual anti-platelet therapy; MI; myocardial infarction; NACE; net adverse cardiovascular event; PCI; percutaneous coronary interven
Keywords: عروق خونی هدف; Acute coronary syndrome; Antiplatelet therapy; Ticagrelor; Clopidogrel; In-stent thrombosis; Target vessel revascularization;
Keywords: عروق خونی هدف; BRS; bioresorbable scaffold; DAPT; dual antiplatelet therapy; MACE; major adverse cardiac event; ST; stent or scaffold thrombosis; TAT; triple antithrombotic therapy; TLF; target lesion failure; TLR; target lesion revascularization; TVF; target vessel fai
Keywords: عروق خونی هدف; ASAN MAIN; ASAN Medical Center-Left MAIN Revascularization; BMS; bare-metal stents; CABG; coronary artery bypass grafting; CI; confidence interval; DES; drug-eluting stent; EES; everolimus-eluting stents; LE MANS; Left Main Coronary Artery Stenting; MACCE
Keywords: عروق خونی هدف; drug-coated balloon; femoropopliteal artery; in-stent restenosis; paclitaxel; peripheral artery disease; ABI; ankle-brachial index; CD; clinically driven; DCB; drug-coated balloon; DES; drug-eluting stent(s); DUS; duplex ultrasonography; ISR; in-stent res
Keywords: عروق خونی هدف; biodegradable polymer; drug-eluting stent(s); durable polymer; meta-analysis; BMS; bare-metal stent(s); BP-DES; biodegradable polymer drug-eluting stent(s); CI; confidence interval; DAPT; dual-antiplatelet therapy; DES; drug-eluting stent(s); DP-DES; dura
Keywords: عروق خونی هدف; Drug-coated balloon; Drug-eluting balloon; In-stent restenosis; Percutaneous coronary intervention; Paclitaxel; Ballon médicamenté; Athérosclérose; Resténose intra-stent; Angioplastie percutanée; Paclitaxel; AMI; acute myocardial infarction; BMS; ba
Keywords: عروق خونی هدف; clinical outcome; fractional flow reserve; stable angina; vessel related; CI; confidence interval; CV; cardiovascular; FFR; fractional flow reserve; HR; hazard ratio; MACE; major adverse cardiovascular event; MI; myocardial infarction; MT; medical therapy
Keywords: عروق خونی هدف; Percutaneous coronary intervention; In-stent restenosis; Neointimal hyperplasia; Target vessel revascularization; Target lesion revascularization;
Keywords: عروق خونی هدف; CABG; coronary artery bypass graft; DES; drug-eluting stents; LMCA; left main coronary artery; MI; myocardial infarction; PCI; percutaneous coronary intervention; PS; propensity score; TVR; target vessel revascularization; 23;
Outcomes After Left Main Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting According to Lesion Site
Keywords: عروق خونی هدف; EXCEL; left main stem; lesion site; substudy; CABG; coronary artery bypass grafting; CI; confidence interval; CoCr-EES; cobalt chromium everolimus-eluting stent(s); LM; left main coronary artery; LMCAD; left main coronary artery disease; MI; myocardial in
The Timing of P2Y12 Inhibitor Initiation in the Treatment of ACS? Does the Evidence Exist in This Era?
Keywords: عروق خونی هدف; ACS; Acute coronary syndrome; PCI; Percutaneous coronary intervention; CABG; Coronary artery bypass grafting; STEMI; ST-segment elevation myocardial infarction; NSTEMI; Non-ST-segment elevation myocardial infarction; MI; Myocardial infarction; CV; Cardiov
Association between P2RY12 gene polymorphisms and adverse clinical events in coronary artery disease patients treated with clopidogrel: A systematic review and meta-analysis
Keywords: عروق خونی هدف; P2RY12; P2Y12 Purinoceptor; CAD; coronary artery disease; RR; risk ratio; ADP; adenosine diphosphate; MI; non-fatal myocardial infarction; ST; stent thrombosis; UA; unstable angina; TVR; target vessel revascularization; NOS; Newcastle-Ottawa scale; CI; co
Clinical Outcomes of patients with coronary artery disease who underwent FFR evaluation of intermediate coronary lesionS- COFFRS study
Keywords: عروق خونی هدف; ACS; Acute Coronary Syndrome; CABG; Coronary Artery Bypass Graft; CAD; Coronary Artery Disease; COURAGE Trial; Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial; DEFER Trial; measurement of fractional flow reserv
Biodegradable Polymer Biolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents in Patients With Coronary Artery Disease
Keywords: عروق خونی هدف; biodegradable polymer-coated stent(s); biolimus-eluting stent(s); everolimus-eluting stent(s); Nobori; Promus; Xience; BES; biolimus-eluting stent(s); BP-BES; biodegradable polymer biolimus-eluting stent(s); DES; drug-eluting stent(s); DP-EES; durable pol
9-Month Clinical and Angiographic Outcomes of the COBRA Polyzene-F NanoCoated Coronary Stent System
Keywords: عروق خونی هدف; restenosis; stent(s); thrombosis; BMS; bare-metal stent(s); CI; confidence interval; CKMB; creatine kinase-MB; DAPT; dual antiplatelet therapy; DES; drug-eluting stent(s); LL; lumen loss; MI; myocardial infarction; PzF; Polyzene-F; QCA; quantitative cor
Long-Term Safety and Efficacy of Platinum Chromium Everolimus-Eluting Stents in Coronary Artery Disease
Keywords: عروق خونی هدف; coronary artery disease; drug-eluting stent(s); percutaneous coronary intervention; stent design; CABG; coronary artery bypass grafting; CI; confidence interval; CoCr-EES; cobalt chromium everolimus-eluting stent(s); HR; hazard ratio; LL; long lesions; MI
Comparison of Durable-Polymer Zotarolimus-Eluting and Biodegradable-Polymer Biolimus-Eluting Coronary Stents in Patients With Coronary Artery Disease
Keywords: عروق خونی هدف; biolimus; drug-eluting; polymer; randomized clinical trial; stent; zotarolimus; DES; drug-eluting stent(s); MACE; major adverse cardiac event(s); MI; myocardial infarction; PCI; percutaneous coronary intervention; ST; stent thrombosis; TLR; target lesion
The DELTA 2 Registry
Keywords: عروق خونی هدف; drug-eluting stents; left main coronary artery; CABG; coronary artery bypass grafting; CI; confidence interval; CVA; cerebrovascular accident; DES; drug-eluting stent(s); HR; hazard ratio; MACCE; major adverse cardiac and cerebrovascular events(s); MI; my
Should We Still Have Bare-Metal Stents Available in Our Catheterization Laboratory?
Keywords: عروق خونی هدف; drug-eluting stent; dual antiplatelet therapy; high bleeding risk patients; in-stent restenosis; stent thrombogenicity; stent thrombosis; BA9; biolimus A9; BMS; bare-metal stent(s); DAPT; dual antiplatelet therapy; DES; drug-eluting stent(s); EES; everoli
What is the optimal approach to a non- culprit stenosis after ST-elevation myocardial infarction - Conservative therapy or upfront revascularization? An updated meta-analysis of randomized trials
Keywords: عروق خونی هدف; CR; complete revascularization; MACE; major adverse cardiovascular events; PCI; percutaneous coronary intervention; STEMI; ST-segment elevation myocardial infarction; TVR; target vessel revascularization; Multi-vessel coronary artery disease; ST-elevation
Computing Methods for Composite Clinical Endpoints in Unprotected Left Main Coronary Artery Revascularization
Keywords: عروق خونی هدف; Andersen-Gill; competing risk; left main; weighted composite event(s); win ratio; CABG; coronary artery bypass grafting; CI; confidence interval; CVA; cerebrovascular accident; HR; hazard ratio; MACCE; major adverse cardiac or cerebrovascular event(s); MI
Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Patients With and Without Acute Coronary Syndrome
Keywords: عروق خونی هدف; ACC; American College of Cardiology; ACS; acute coronary syndrome; AHA; American Heart Association; BMS; bare metal stent; CI; contraindication; CKD; chronic kidney disease; CTO; chronic total occlusion; DAPT; dual antiplatelet therapy; DES; drug-eluting
Impact of the learning curve on procedural results and acute outcome after percutaneous coronary interventions with everolimus-eluting bioresorbable scaffolds in an all-comers population
Keywords: عروق خونی هدف; BVS; bioresorbable vascular scaffold; DES; drug-eluting stent; IVUS; intravascular ultrasound; MACE; major adverse cardiac event; OCT; optical coherence tomography; PLLA; poly-L-lactic acid; SD; standard deviation; TLR; target lesion revascularization; TV
Safety and efficacy of everolimus-eluting stent versus zotarolimus-eluting stent: A meta-analysis of randomized controlled clinical trials and observational studies
Keywords: عروق خونی هدف; EES; everolimus-eluting stent; ZES; zotarolimus-eluting stent; RCTs; randomized controlled clinical trials; MACE; major adverse cardiac events; MI; myocardial infarction; ST; stent thrombosis; TVR; target vessel revascularization; TLR; target lesion revas
Summary of the ESC/EACTS 2014 Guidelines on myocardial revascularization. Prepared by the Czech Society of Cardiology
Keywords: عروق خونی هدف; ACCF/AHA; American College of Cardiology Foundation/American Heart Association; ACS; acute coronary syndromes; AF; atrial fibrillation; ASA; acetylsalicylic acid; BMS; bare-metal stent; CABG; coronary artery bypass grafting; CAD; coronary artery disease;
Impact of previous coronary artery bypass surgery on clinical outcome after percutaneous interventions with second generation drug-eluting stents in TWENTE trial and Non-Enrolled TWENTE registry
Keywords: عروق خونی هدف; DES; drug-eluting stent; PCI; percutaneous coronary intervention; STEMI; ST-elevation myocardial infarction; TVR; target vessel revascularization; Non-ST-ACS; non-ST-elevation acute coronary syndromes; CABG; coronary artery bypass grafting; Drug-eluting s
Dedicated Tryton Side Branch Stents used in the treatment of coronary bifurcation lesions
Keywords: عروق خونی هدف; MS-CT; multi-slice CT coronarography; MIP; maximum intensity projection; PCI; percutaneous coronary intervention; MACE; major adverse cardiovascular events; ISR; in-stent restenosis; TVR; target vessel revascularization; LM; left main stem; LAD; left ante
Serum albumin and C-reactive protein levels predict clinical outcome in hemodialysis patients undergoing endovascular therapy for peripheral artery disease
Keywords: عروق خونی هدف; Hemodialysis; Endovascular; Follow-up studies; Stent; Target vessel revascularization;
Prospective, randomized evaluation of thrombectomy prior to percutaneous intervention in diseased saphenous vein grafts and thrombus-containing coronary arteries
Keywords: عروق خونی هدف; CPK; creatine phosphokinase; GP; glycoprotein; MACE; major adverse cardiac events; MI; myocardial infarction; PCI; percutaneous coronary intervention; SVG; saphenous vein graft; TIMI; Thrombolysis In Myocardial Infarction; TVR; target vessel revasculariza
Effect of gender on repeated coronary artery revascularization after intra-coronary stenting: A meta-analysis
Keywords: عروق خونی هدف; Coronary artery disease; Gender; Stent; Target vessel revascularization; Major adverse cardiac events;
Single-Center Experience in Endovascular Treatment for Infrainguinal Bypass Obstructions
Keywords: عروق خونی هدف; CLI; critical limb ischemia; HR; hazard ratio; IC; intermittent claudication; PTA; percutaneous transluminal angioplasty; TLR; target lesion revascularization; TVR; target vessel revascularization;
Drug-Eluting Stents Compared With Bilateral Internal Thoracic Artery Grafts for Diabetic Patients
Keywords: عروق خونی هدف; BITA; bilateral internal thoracic artery; CABG; coronary artery bypass graft surgery; CAD; coronary artery disease; CI; confidence interval; DES; drug-eluting stent; HR; hazard ratio; ITA; internal thoracic artery; LAD; left anterior descending artery; MA
Percutaneous Lower-extremity Arterial Interventions with Primary Balloon Angioplasty Versus SilverHawk Atherectomy and Adjunctive Balloon Angioplasty: Randomized Trial
Keywords: عروق خونی هدف; PTA; percutaneous transluminal angioplasty; TLR; target lesion revascularization; TVR; target vessel revascularization;
Prediction of 1-Year Clinical Outcomes Using the SYNTAX Score in Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention : A Substudy of the STRATEGY (Single High-Dose Bolus Tirofiban and Siroli
Keywords: عروق خونی هدف; infarct-related artery; major adverse cardiac events; percutaneous coronary intervention; stenting; stent thrombosis; ST-segment elevation myocardial infarction; SYNTAX score; target vessel revascularization; Thrombolysis In Myocardial InfarctionBMS, bare
5-Year Follow-Up of Polytetrafluoroethylene-Covered Stents Compared With Bare-Metal Stents in Aortocoronary Saphenous Vein Grafts
Keywords: عروق خونی هدف; bypass graft; coronary artery disease; stent; BMS; bare-metal stent(s); CABG; coronary artery bypass graft surgery; CPK; creatine phosphokinase; DES; drug-eluting stent(s); IVUS; intravascular ultrasound; PCI; percutaneous coronary intervention; PTFE; pol
Different effects of thiazolidinediones on target vessel revascularization with bare metal stents: a meta-analysis
Keywords: عروق خونی هدف; Coronary stent; Pioglitazone; Restenosis; Rosiglitazone; Target vessel revascularization
Value of the SYNTAX Score for Risk Assessment in the All-Comers Population of the Randomized Multicenter LEADERS (Limus Eluted from A Durable versus ERodable Stent coating) Trial
Keywords: عروق خونی هدف; biodegradable polymer; biolimus-eluting stent; major adverse cardiac event; prognostic value; sirolimus-eluting stent; target vessel revascularization; SYNTAX scoreCI, confidence interval; HR, hazard ratio; MACE, major adverse cardiac event(s); MI, myocar
Use of Drug-Eluting Stents in Patients With Coronary Artery Disease and Renal Insufficiency
Keywords: عروق خونی هدف; ADMA; asymmetric dimethylarginine; BMS; bare-metal stent; CAD; coronary artery disease; CIN; contrast agent-induced nephropathy; DES; drug-eluting stent; DM; diabetes mellitus; MACE; major adverse cardiac event; MI; myocardial infarction; PCI; percutane
Incidence and Predictors of Very Late (â¥4 Years) Major Cardiac Adverse Events in the DESIRE (Drug-Eluting Stents in the Real World)-Late Registry
Keywords: عروق خونی هدف; drug-eluting stents; stent thrombosis; very long-term outcomes; BMS; bare-metal stent(s); CI; confidence interval; CK; creatine kinase; DES; drug-eluting stent(s); DS; diameter stenosis; HR; hazard ratio; MACE; major adverse cardiac events; MLD; minimum l
Safety and Efficacy of Renal Artery Stenting Following Suboptimal Renal Angioplasty for De Novo and Restenotic Ostial Lesions: Results from a Nonrandomized, Prospective Multicenter Registry
Keywords: عروق خونی هدف; MACE; major adverse clinical event(s); PSV; peak systolic velocity; PTRA; percutaneous transluminal renal angioplasty; QOL; quality of life; SOAR; Suboptimal Renal Angioplasty Results; TLR; target lesion revascularization; TVR; target vessel revasculariza
Efficacy of Cilostazol After Endovascular Therapy for Femoropopliteal Artery Disease in Patients With Intermittent Claudication
Keywords: عروق خونی هدف; femoropopliteal arterial disease; target vessel revascularization; restenosis; endovascular therapyEVT, endovascular therapy; IC, intermittent claudication; MACE, major adverse cardiovascular events; MI, myocardial infarction; PAD, peripheral arterial dis
Impact of Sex on 3-Year Outcome After Percutaneous Coronary Intervention Using Bare-Metal and Drug-Eluting Stents in Previously Untreated Coronary Artery Disease: Insights From the RESEARCH (Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospit
Keywords: عروق خونی هدف; percutaneous coronary intervention; bare-metal stent; drug-eluting stent; major adverse cardiac event; myocardial infarction; target vessel revascularization; target lesion revascularizationBMS, bare-metal stent(s); DES, drug-eluting stent(s); MACE, major
Safety and Effectiveness of the Endeavor Zotarolimus-Eluting Stent in Real-World Clinical Practice
Keywords: عروق خونی هدف; coronary artery lesion; drug-eluting stent; multicenter registry; restenosis; stent thrombosis; ARC; Academic Research Consortium; BMS; bare-metal stent(s); CEC; clinical events committee; CK-MB; creatine kinase-myocardial band; DES; drug-eluting stent(s)
Unprotected Left Main Intervention
Keywords: عروق خونی هدف; CABG; coronary artery bypass graft; DES; drug-eluting stent(s); IVUS; intravascular ultrasound; LAD; left anterior descending artery; PES; paclitaxel-eluting stent(s); SES; sirolimus-eluting stent(s); TLR; target lesion revascularization; TVR; target vess
Geographical Differences in the Rates of Angiographic Restenosis and Ischemia-Driven Target Vessel Revascularization After Percutaneous Coronary Interventions
Keywords: عروق خونی هدف; ACC/AHA; American College of Cardiology/American Heart Association; MI; myocardial infarction; PCI; percutaneous coronary intervention; TVF; target vessel failure; TVR; target vessel revascularization;
Long-Term Clinical Outcome After Fractional Flow Reserve-Guided Percutaneous Coronary Intervention in Patients With Multivessel Disease
Keywords: عروق خونی هدف; ACS; acute coronary syndrome; %DS; percent diameter stenosis; FFR; fractional flow reserve; LAD; left anterior descending artery; LCx; left circumflex artery; MI; myocardial infarction; MLD; minimal lumen diameter; RCA; right coronary artery; RD; referenc
Application of Evidence-Based Medical Therapy Is Associated With Improved Outcomes After Percutaneous Coronary Intervention and Is a Valid Quality Indicator
Keywords: عروق خونی هدف; ACE; angiotensin-converting enzyme; CABG; coronary artery bypass graft surgery; CHF; congestive heart failure; CI; confidence interval; HR; hazard ratio; MEDS; medication score; MI; myocardial infarction; PCI; percutaneous coronary intervention; TVR; targ
Gender-based outcomes after paclitaxel-eluting stent implantation in patients with coronary artery disease
Keywords: عروق خونی هدف; CI; confidence interval; MACE; major adverse cardiac events; OR; odds ratio; TLR; target lesion revascularization; TVR; target vessel revascularization;